News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AB Science (AB.PA): CAB Reviews and VetMed Resources Publish a Comprehensive Review on the Clinical Development of Masitinib in Veterinary Medicine


6/29/2011 11:19:17 AM

PARIS--(BUSINESS WIRE)--AB Science SA (Paris:AB)(NYSE-Euronext, FR0010557264, AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, announces the publication of a wide-ranging review article entitled ‘Masitinib – a targeted therapy with applications in veterinary oncology and inflammatory diseases’ in the peer-reviewed journal CAB Reviews and on the veterinary continuing education website VetMed Resources.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES